Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia
article
OA: closed
CC0
⤵ 25 in-corpus citations
AI-generated summary
Menorrhagia is associated with reduced VEGF-A and active MMP-2/MMP-9, and increased TNF-α in endometrial effluent and endometrium.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Heavy regular menstrual periods (menorrhagia) are an important cause of ill health in women and remain the leading indication for hysterectomy. Abnormalities of the endometrial blood vessels are among the possible causes of this condition. Many different factors affect endothelial cell growth, function and vessel remodelling. We sought to determine whether the levels of vascular endothelial growth factor-A (VEGF-A), tumour necrosis factor-alpha (TNF-alpha), matrix metalloproteinase (MMP)-2 and MMP-9 and soluble VEGF receptor-1 (VEGF-R1) were altered in the menstrual effluent of women with objective menorrhagia. We have also quantitated the VEGF-A mRNA in the menstruated endometrium. METHODS AND RESULTS: We recruited 37 women and determined their menstrual blood loss (MBL) over two cycles and collected menstrual effluent during the 2nd day of bleeding for 4 h. There was no difference in the total level of VEGF-A, and neither latent MMP. However, the concentration of VEGF-A was significantly reduced in the women with menorrhagia, as was the VEGF-A mRNA level. In addition, the active forms of both MMPs were markedly reduced and the total sVEGF-R1 as well as the TNF-alpha content were increased. CONCLUSIONS: This is the first study to show abnormalities of factors important for endothelial cell behaviour in the endometrium of women with menorrhagia. This may underlie the disordered vessel structure and/or function in this condition.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (75)
- Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation via openalex
- MORPHOLOGY OF HAEMOSTASIS IN MENSTRUAL ENDOMETRIUM via openalex
- Premenstrual and Menstrual Changes in the Macaque and Human Endometrium via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- Regulation of Matrix Metalloproteinase-9/Gelatinase B Expression and Activation by Ovarian Steroids and LEFTY-A/Endometrial Bleeding-Associated Factor in the Human Endometrium via openalex
- Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia<sup>1</sup> via openalex
- Vascular Repair After Menstruation Involves Regulation of Vascular Endothelial Growth Factor-Receptor Phosphorylation by sFLT-1 via openalex
- Vascular smooth muscle cell proliferation in arterioles of the human endometrium via openalex
- doi:10.1038/386616a0 via openalex
- doi:10.1073/pnas.90.22.10705 via openalex
- doi:10.1111/j.1471-0528.1996.tb09556.x via openalex
- doi:10.1073/pnas.84.15.5277 via openalex
- doi:10.1096/fj.00-0247com via openalex
- doi:10.1016/s0002-9378(16)34090-x via openalex
- doi:10.1074/jbc.m107783200 via openalex
- doi:10.1074/jbc.m105474200 via openalex
- doi:10.3109/00016346609158476 via openalex
- doi:10.1111/j.1471-0528.1995.tb11293.x via openalex
- doi:10.1172/jci118816 via openalex
- doi:10.1016/s0092-8674(00)81169-1 via openalex
- doi:10.1042/0264-6021:3580275 via openalex
- doi:10.1161/01.res.87.8.670 via openalex
- doi:10.1210/mend.13.4.0265 via openalex
- doi:10.1074/jbc.m307688200 via openalex
- doi:10.1161/01.res.75.3.539 via openalex
- W2106494357 via openalex
- doi:10.1093/molehr/2.2.77 via openalex
- doi:10.1186/1476-4598-2-25 via openalex
- doi:10.1095/biolreprod61.4.1070 via openalex
- doi:10.1111/j.1471-0528.1984.tb04827.x via openalex
- doi:10.1093/clinchem/47.4.617 via openalex
- doi:10.1095/biolreprod59.6.1540 via openalex
- doi:10.1016/s0046-8177(97)90110-6 via openalex
- doi:10.1136/bmj.313.7057.579 via openalex
- doi:10.1016/s0015-0282(98)00044-2 via openalex
- doi:10.1172/jci117461 via openalex
- doi:10.1096/fj.01-0178com via openalex
- doi:10.1172/jci119868 via openalex
- doi:10.1210/jcem.87.5.8487 via openalex
- doi:10.1006/abio.1987.9999 via openalex
- doi:10.1111/j.1749-6632.1994.tb21736.x via openalex
- doi:10.1093/humrep/16.6.1065 via openalex
- doi:10.1056/nejm199303253281207 via openalex
- doi:10.1093/humrep/15.suppl_3.112 via openalex
- doi:10.1210/en.2002-220641 via openalex
- doi:10.1093/oxfordjournals.humrep.a135790 via openalex
- doi:10.1016/0003-2697(87)90021-2 via openalex
- doi:10.1042/bj3580275 via openalex
- doi:10.1016/0002-9378(78)90119-9 via openalex
- doi:10.1210/jc.85.1.402 via openalex
- doi:10.1161/res.90.3.251 via openalex
- W2396929965 via openalex
- W6600711243 via openalex
- W6602545331 via openalex
- W6716698088 via openalex
- W6834787679 via openalex
- W6841515843 via openalex
- doi:10.1002/(sici)1097-0215(19980302)75:5<780::aid-ijc19>3.0.co;2-a via openalex
- doi:10.1161/01.res.0000111527.42357.62 via openalex
- doi:10.4049/jimmunol.171.8.4340 via openalex
- doi:10.1136/jcp.37.8.879 via openalex
- doi:10.1074/jbc.272.51.32521 via openalex
- doi:10.1038/labinvest.3780050 via openalex
- doi:10.1182/blood.v97.5.1321 via openalex
- doi:10.1161/hh1501.094269 via openalex
- doi:10.1023/a:1023889805133 via openalex
- W17439236 via openalex
- doi:10.1074/jbc.273.8.4400 via openalex
- W63062164 via openalex
- doi:10.1055/s-0038-1661182 via openalex
- doi:10.1023/a:1009292506879 via openalex
- doi:10.1007/bf00667681 via openalex
- doi:10.1016/s0140-6736(81)92862-2 via openalex
- doi:10.1016/0002-9378(71)90259-6 via openalex
- doi:10.1093/oxfordjournals.humrep.a135928 via openalex
Cited by (22)
- The composition of menstrual fluid, its applications, and recent advances to understand the endometrial environment: a narrative review 2024
- Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology 2023
- Decreased Glycolysis at Menstruation is Associated with Increased Menstrual Blood Loss 2022
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- Obesity is associated with heavy menstruation that may be due to delayed endometrial repair 2021
- Menstruation Dysregulation and Endometriosis Development 2021
- Circulating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle 2020
- Efficacy of <i>Habbul aas</i> (fruits of <i>Myrtus communis</i> ) in menorrhagia: a single blinded randomized standard control study 2020
- Angiogenetic and hereditary factors in endometrial disease 2019
- Harmonization of Clinical and Laboratory Data to Improve Biomarker Discovery in Endometriosis: WERF EPHect 2017
- Heavy menstrual bleeding diagnosis and medical management 2017
- Menstrual physiology: implications for endometrial pathology and beyond 2015
- World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research 2014
- A Novel Pilot Study of Endometrial Stromal Cells and Immune Cell Populations in Sentinel Uterine-Draining Lymph Nodes During the Menstrual Cycle and in Endometriosis 2013
- Immunology of Normal and Abnormal Menstruation 2013
- Progesterone: a pivotal hormone at menstruation 2011
- Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis 2010
- Cortisol Inactivation by 11β-Hydroxysteroid dehydrogenase-2 May Enhance Endometrial Angiogenesis via Reduced Thrombospondin-1 in Heavy Menstruation 2009
- Enhanced expressions of matrix metalloproteinase (MMP)-2 and –9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding 2009
- Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis 2007
- Endometrial bleeding 2007
Source provenance
- openalex
- last seen: 2026-05-11T06:16:32.963054+00:00
- unpaywall
- last seen: 2026-08-23T06:29:45.520198+00:00
License: CC0
· commercial use OK